Sweden
· Delayed Price · Currency is SEK Bonesupport Holding AB Company Description
Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft substitute that remodels to host bone and elutes Vancomycin during the critical first 30 days of bone healing, as well as treats and prevents bone infection.
It also offers CERAMENT Bead Tray, an adjunctive local delivery option for surgeons for targeted delivery to osseous defects and for dead space management.
In addition, the company develops preclinical product candidates to promote bone regrowth focusing on trauma, revision arthroplasty, chronic osteomyelitis, and foot and ankle surgery.
Bonesupport Holding AB (publ) was founded in 1999 and is headquartered in Lund, Sweden.
| Country | Sweden |
| Founded | 1999 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 139 |
| CEO | Emil Billbäck |
Contact Details
Address: Scheelevägen 19 Lund, 223 70 Sweden | |
| Phone | 46 4 62 86 53 70 |
| Website | bonesupport.com |
Stock Details
| Ticker Symbol | BONEX |
| Exchange | Nasdaq Stockholm |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| ISIN Number | SE0009858152 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Emil Billbäck | Chief Executive Officer |
| Håkan Johansson | Chief Financial Officer |
| Michael Wrang Mortensen | Executive Vice President of Global Research & Development and Operations |
| Annelie Aava Vikner | Executive Vice President of Global Marketing |
| Helena L. Brandt | Executive Vice President of Human Resources |
| Dr. Michael Diefenbeck M.D., Ph.D. | Executive Vice President of Medical and Clinical Affairs and Chief Medical Officer |
| Fergus MacLeod | GM and Executive Vice President of Commercial Operations of EUROW |
| Michael Roth | GM and Executive Vice President of Commercial Operations of North America |
| Anna Stegmark | Executive Vice President of Quality Management and Regulatory Affairs |